14 February 2024 first patient in extension study dosed as of 13 May no up date on progress after 3 months.
10 March final approval for the remaing 2 patients to commence extension study given as of 13 May no up date on these 2 patients being dosed after one month
- Forums
- ASX - By Stock
- PAA
- Ann: Board Changes
Ann: Board Changes, page-251
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $84.55M |
Open | High | Low | Value | Volume |
19.0¢ | 19.0¢ | 18.5¢ | $2.551K | 13.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 763207 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 253569 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 763207 | 0.185 |
22 | 446147 | 0.180 |
9 | 722400 | 0.175 |
6 | 123823 | 0.170 |
3 | 68000 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 253569 | 4 |
0.195 | 7012 | 1 |
0.200 | 206837 | 5 |
0.205 | 190991 | 6 |
0.210 | 300000 | 2 |
Last trade - 10.52am 03/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online